Deficiency of smarcal1 causes cell cycle arrest and developmental abnormalities in zebrafish

Developmental Biology

Volumn 339, Issue 1, 2010, Pages 89-100

  Huang, Cheng ^a,b   Gu, Shanye ^a   Yu, Pengchun ^a   Yu, Fudong ^a   Feng, Chun ^a   Gao, Ning ^c   Du, Jiulin ^a  

^a Chinese Academy of Sciences   (China)

^b SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

^c THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Apoptosis; Cell cycle; Chromatin remodeling; Development; Schimke Immuno Osseous Dysplasia; Smarcal1

Indexed keywords

HELICASE; MESSENGER RNA; PROTEIN SMARCAL1; PROTEIN SWI TRANSCRIPTION FACTOR SNF RELATED MATRIX ASSOCIATED ACTIN DEPENDENT REGULATOR OF CHROMATIN SUBFAMILY A LIKE 1; TRANSCRIPTION FACTOR E2F6; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CELL CYCLE ARREST; CELL CYCLE G0 PHASE; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CHROMATIN ASSEMBLY AND DISASSEMBLY; CONTROLLED STUDY; CRANIOFACIAL MALFORMATION; DEVELOPMENTAL DISORDER; EMBRYO; GEL MOBILITY SHIFT ASSAY; GENE EXPRESSION; GROWTH RETARDATION; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; SCHIMKE IMMUNO OSSEOUS DYSPLASIA; ZEBRA FISH;

DANIO RERIO;

EID: 77649181041     PISSN: 00121606     EISSN: 1095564X     Source Type: Journal    
DOI: 10.1016/j.ydbio.2009.12.018     Document Type: Article

References (64)

1. Amatruda J.F., Zon L.I. Dissecting hematopoiesis and disease using the zebrafish. Dev. Biol. 1999, 216:1-15.
2. Bennett C.M., Kanki J.P., Rhodes J., Liu T.X., Paw B.H., Kieran M.W., Langenau D.M., Delahaye-Brown A., Zon L.I., Fleming M.D., Look A.T. Myelopoiesis in the zebrafish, Danio rerio. Blood 2001, 98:643-651.
3. Berghmans S., Murphey R.D., Wienholds E., Neuberg D., Kutok J.L., Fletcher C.D., Morris J.P., Liu T.X., Schulte-Merker S., Kanki J.P., Plasterk R., Zon L.I., Look A.T. tp53 mutant zebrafish develop malignant peripheral nerve sheath tumors. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:407-412.
4. Bill B.R., Balciunas D., McCarra J.A., Young E.D., Xiong T., Spahn A.M., Garcia-Lecea M., Korzh V., Ekker S.C., Schimmenti L.A. Development and Notch signaling requirements of the zebrafish choroid plexus. PLoS ONE 2008, e3114:3.
5. Boerkoel C.F., O'Neill S., Andre J.L., Benke P.J., Bogdanovic R., Bulla M., Burguet A., Cockfield S., Cordeiro I., Ehrich J.H., Frund S., Geary D.F., Ieshima A., Illies F., Joseph M.W., Kaitila I., Lama G., Leheup B., Ludman M.D., McLeod D.R., Medeira A., Milford D.V., Ormala T., Rener-Primec Z., Santava A., Santos H.G., Schmidt B., Smith G.C., Spranger J., Zupancic N., Weksberg R. Manifestations and treatment of Schimke immuno-osseous dysplasia: 14 new cases and a review of the literature. Eur. J. Pediatr. 2000, 159:1-7.
6. Boerkoel C.F., Takashima H., John J., Yan J., Stankiewicz P., Rosenbarker L., Andre J.L., Bogdanovic R., Burguet A., Cockfield S., Cordeiro I., Frund S., Illies F., Joseph M., Kaitila I., Lama G., Loirat C., McLeod D.R., Milford D.V., Petty E.M., Rodrigo F., Saraiva J.M., Schmidt B., Smith G.C., Spranger J., Stein A., Thiele H., Tizard J., Weksberg R., Lupski J.R., Stockton D.W. Mutant chromatin remodeling protein SMARCAL1 causes Schimke immuno-osseous dysplasia. Nat. Genet. 2002, 30:215-220.
7. Bokenkamp A., deJong M., van Wijk J.A., Block D., van Hagen J.M., Ludwig M. R561C missense mutation in the SMARCAL1 gene associated with mild Schimke immuno-osseous dysplasia. Pediatr. Nephrol. 2005, 20:1724-1728.
8. Cheung K.J., Badarinarayana V., Selinger D.W., Janse D., Church G.M. A microarray-based antibiotic screen identifies a regulatory role for supercoiling in the osmotic stress response of Escherichia coli. Genome. Res. 2003, 13:206-215.
9. Cho K.R., Hedrick L. Genetic alterations in human tumors. Curr. Top. Microbiol. Immunol. 1997, 221:149-176.
10. Cho K.S., Elizondo L.I., Boerkoel C.F. Advances in chromatin remodeling and human disease. Curr. Opin. Genet. Dev. 2004, 14:308-315.
11. Clewing J.M., Antalfy B.C., Lucke T., Najafian B., Marwedel K.M., Hori A., Powel R.M., Do A.F., Najera L., SantaCruz K., Hicks M.J., Armstrong D.L., Boerkoel C.F. Schimke immuno-osseous dysplasia: a clinicopathological correlation. J. Med. Genet. 2007, 44:122-130.
12. Clewing J.M., Fryssira H., Goodman D., Smithson S.F., Sloan E.A., Lou S., Huang Y., Choi K., Lucke T., Alpay H., Andre J.L., Asakura Y., Biebuyck-Gouge N., Bogdanovic R., Bonneau D., Cancrini C., Cochat P., Cockfield S., Collard L., Cordeiro I., Cormier-Daire V., Cransberg K., Cutka K., Deschenes G., Ehrich J.H., Frund S., Georgaki H., Guillen-Navarro E., Hinkelmann B., Kanariou M., Kasap B., Kilic S.S., Lama G., Lamfers P., Loirat C., Majore S., Milford D., Morin D., Ozdemir N., Pontz B.F., Proesmans W., Psoni S., Reichenbach H., Reif S., Rusu C., Saraiva J.M., Sakallioglu O., Schmidt B., Shoemaker L., Sigaudy S., Smith G., Sotsiou F., Stajic N., Stein A., Stray-Pedersen A., Taha D., Taque S., Tizard J., Tsimaratos M., Wong N.A., Boerkoel C.F. Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum. Mutat. 2007, 28:273-283.
13. Coleman M.A., Eisen J.A., Mohrenweiser H.W. Cloning and characterization of HARP/SMARCAL1: a prokaryotic HepA-related SNF2 helicase protein from human and mouse. Genomics 2000, 65:274-282.
14. Dai X., Rothman-Denes L.B. DNA structure and transcription. Curr. Opin. Microbiol. 1999, 2:126-130.
15. DeGregori J., Johnson D.G. Distinct and overlapping roles for E2F family members in transcription, proliferation and apoptosis. Curr. Mol. Med. 2006, 6:739-748.
16. Deguchi K., Clewing J.M., Elizondo L.I., Hirano R., Huang C., Choi K., Sloan E.A., Lucke T., Marwedel K.M., Powell R.D., Santa Cruz K., Willaime-Morawek S., Inoue K., Lou S., Northrop J.L., Kanemura Y., van der Kooy D., Okano H., Armstrong D.L., Boerkoel C.F. Neurologic phenotype of Schimke immuno-osseous dysplasia and neurodevelopmental expression of SMARCAL1. J. Neuropathol. Exp. Neurol. 2008, 67:565-577.
17. Dooley K., Zon L.I. Zebrafish: a model system for the study of human disease. Curr. Opin. Genet. Dev. 2000, 10:252-256.
18. Eisen J.S., Smith J.C. Controlling morpholino experiments: don't stop making antisense. Development 2008, 135:1735-1743.
19. Ekker S.C., Larson J.D. Morphant technology in model developmental systems. Genesis 2001, 30:89-93.
20. Elizondo L.I., Huang C., Northrop J.L., Deguchi K., Clewing J.M., Armstrong D.L., Boerkoel C.F. Schimke immuno-osseous dysplasia: a cell autonomous disorder?. Am. J. Med. Genet. A 2006, 140:340-348.
21. Felsenstein J. Comparative methods with sampling error and within-species variation: contrasts revisited and revised. Am. Nat. 2008, 171:713-725.
22. Gabellini C., Del Bufalo D., Zupi G. Involvement of RB gene family in tumor angiogenesis. Oncogene 2006, 25:5326-5332.
23. Gamse J.T., Shen Y.C., Thisse C., Thisse B., Raymond P.A., Halpern M.E., Liang J.O. Otx5 regulates genes that show circadian expression in the zebrafish pineal complex. Nat. Genet. 2002, 30:117-121.
24. Gangaraju V.K., Bartholomew B. Mechanisms of ATP dependent chromatin remodeling. Mutat. Res. 2007, 618:3-17.
25. Gering M., Patient R. Hedgehog signaling is required for adult blood stem cell formation in zebrafish embryos. Dev. Cell 2005, 8:389-400.
26. Gongal P.A., Waskiewicz A.J. Zebrafish model of holoprosencephaly demonstrates a key role for TGIF in regulating retinoic acid metabolism. Hum. Mol. Genet. 2008, 17:525-538.
27. Griffin C.T., Brennan J., Magnuson T. The chromatin-remodeling enzyme BRG1 plays an essential role in primitive erythropoiesis and vascular development. Development 2008, 135:493-500.
28. Hendzel M.J., Wei Y., Mancini M.A., Van Hooser A., Ranalli T., Brinkley B.R., Bazett-Jones D.P., Allis C.D. Mitosis-specific phosphorylation of histone H3 initiates primarily within pericentromeric heterochromatin during G2 and spreads in an ordered fashion coincident with mitotic chromosome condensation. Chromosoma 1997, 106:348-360.
29. Horsfield J.A., Anagnostou S.H., Hu J.K., Cho K.H., Geisler R., Lieschke G., Crosier K.E., Crosier P.S. Cohesin-dependent regulation of Runx genes. Development 2007, 134:2639-2649.
30. Huang C., Sloan E.A., Boerkoel C.F. Chromatin remodeling and human disease. Curr. Opin. Genet. Dev. 2003, 13:246-252.
31. Huang C., Zhang Y., Gong Z., Sheng X., Li Z., Zhang W., Qin Y. Berberine inhibits 3T3-L1 adipocyte differentiation through the PPARgamma pathway. Biochem. Biophys. Res. Commun. 2006, 348:571-578.
32. Isogai S., Lawson N.D., Torrealday S., Horiguchi M., Weinstein B.M. Angiogenic network formation in the developing vertebrate trunk. Development 2003, 130:5281-5290.
33. Iuchi I., Yamamoto M. Erythropoiesis in the developing rainbow trout, Salmo gairdneri irideus: histochemical and immunochemical detection of erythropoietic organs. J. Exp. Zool. 1983, 226:409-417.
34. Jia S., Ren Z., Li X., Zheng Y., Meng A. smad2 and smad3 are required for mesendoderm induction by transforming growth factor-beta/nodal signals in zebrafish. J. Biol. Chem. 2008, 283:2418-2426.
35. Kadam S., Emerson B.M. Mechanisms of chromatin assembly and transcription. Curr. Opin. Cell Biol. 2002, 14:262-268.
36. Kalev-Zylinska M.L., Horsfield J.A., Flores M.V., Postlethwait J.H., Vitas M.R., Baas A.M., Crosier P.S., Crosier K.E. Runx1 is required for zebrafish blood and vessel development and expression of a human RUNX1-CBF2T1 transgene advances a model for studies of leukemogenesis. Development 2002, 129:2015-2030.
37. Korenjak M., Brehm A. E2F-Rb complexes regulating transcription of genes important for differentiation and development. Curr. Opin. Genet. Dev. 2005, 15:520-527.
38. Koshida S., Shinya M., Mizuno T., Kuroiwa A., Takeda H. Initial anteroposterior pattern of the zebrafish central nervous system is determined by differential competence of the epiblast. Development 1998, 125:1957-1966.
39. Kumar S., Tamura K., Nei M. MEGA3: integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinform. 2004, 5:150-163.
40. Lam E.Y., Chau J.Y., Kalev-Zylinska M.L., Fountaine T.M., Mead R.S., Hall C.J., Crosier P.S., Crosier K.E., Flores M.V. Zebrafish runx1 promoter-EGFP transgenics mark discrete sites of definitive blood progenitors. Blood 2009, 113:1241-1249.
41. Langenau D.M., Zon L.I. The zebrafish: a new model of T-cell and thymic development. Nat. Rev. Immunol. 2005, 5:307-317.
42. Lehner C.F., O'Farrell P.H. Expression and function of Drosophila cyclin A during embryonic cell cycle progression. Cell 1989, 56:957-968.
43. Lim H.M., Lewis D.E., Lee H.J., Liu M., Adhya S. Effect of varying the supercoiling of DNA on transcription and its regulation. Biochemistry 2003, 42:10718-10725.
44. Liu T.X., Howlett N.G., Deng M., Langenau D.M., Hsu K., Rhodes J., Kanki J.P., D'Andrea A.D., Look A.T. Knockdown of zebrafish Fancd2 causes developmental abnormalities via p53-dependent apoptosis. Dev. Cell 2003, 5:903-914.
45. MacLachlan T.K., El-Deiry W.S. Apoptotic threshold is lowered by p53 transactivation of caspase-6. Proc. Natl. Acad. Sci. U. S. A. 2002, 99:9492-9497.
46. Maroon H., Walshe J., Mahmood R., Kiefer P., Dickson C., Mason I. Fgf3 and Fgf8 are required together for formation of the otic placode and vesicle. Development 2002, 129:2099-2108.
47. McReynolds L.J., Gupta S., Figueroa M.E., Mullins M.C., Evans T. Smad1 and Smad5 differentially regulate embryonic hematopoiesis. Blood 2007, 110:3881-3890.
48. Nasevicius A., Ekker S.C. Effective targeted gene 'knockdown' in zebrafish. Nat. Genet. 2000, 26:216-220.
49. Nicoli S., Presta M. The zebrafish/tumor xenograft angiogenesis assay. Nat. Protoc. 2007, 2:2918-2923.
50. Ogawa H., Ishiguro K., Gaubatz S., Livingston D.M., Nakatani Y. A complex with chromatin modifiers that occupies E2F-and Myc-responsive genes in G0 cells. Science 2002, 296:1132-1136.
51. Patterson L.J., Gering M., Eckfeldt C.E., Green A.R., Verfaillie C.M., Ekker S.C., Patient R. The transcription factors Scl and Lmo2 act together during development of the hemangioblast in zebrafish. Blood 2007, 109:2389-2398.
52. Ransom D.G., Haffter P., Odenthal J., Brownlie A., Vogelsang E., Kelsh R.N., Brand M., van Eeden F.J., Furutani-Seiki M., Granato M., Hammerschmidt M., Heisenberg C.P., Jiang Y.J., Kane D.A., Mullins M.C., Nusslein-Volhard C. Characterization of zebrafish mutants with defects in embryonic hematopoiesis. Development 1996, 123:311-319.
53. Robu M.E., Larson J.D., Nasevicius A., Beiraghi S., Brenner C., Farber S.A., Ekker S.C. p53 activation by knockdown technologies. PLoS Genet. 2007, 3:e78.
54. Salmon K., Hung S.P., Mekjian K., Baldi P., Hatfield G.W., Gunsalus R.P. Global gene expression profiling in Escherichia coli K12. The effects of oxygen availability and FNR. J. Biol. Chem. 2003, 278:29837-29855.
55. Sawalha A.H. Epigenetics and T-cell immunity. Autoimmunity 2008, 41:245-252.
56. Shepard J.L., Stern H.M., Pfaff K.L., Amatruda J.F. Analysis of the cell cycle in zebrafish embryos. Methods Cell Biol. 2004, 76:109-125.
57. Sprenger F., Yakubovich N., O'Farrell P.H. S-phase function of Drosophila cyclin A and its downregulation in G1 phase. Curr. Biol. 1997, 7:488-499.
58. Trimarchi J.M., Fairchild B., Verona R., Moberg K., Andon N., Lees J.A. E2F-6, a member of the E2F family that can behave as a transcriptional repressor. Proc. Natl. Acad. Sci. U. S. A. 1998, 95:2850-2855.
59. Vidal A., Koff A. Cell-cycle inhibitors: three families united by a common cause. Gene 2000, 247:1-15.
60. Wang G.G., Allis C.D., Chi P. Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling. Trends Mol. Med. 2007, 13:373-380.
61. Wu L., Timmers C., Maiti B., Saavedra H.I., Sang L., Chong G.T., Nuckolls F., Giangrande P., Wright F.A., Field S.J., Greenberg M.E., Orkin S., Nevins J.R., Robinson M.L., Leone G. The E2F1-3 transcription factors are essential for cellular proliferation. Nature 2001, 414:457-462.
62. Yamauchi H., Hotta Y., Konishi M., Miyake A., Kawahara A., Itoh N. Fgf21 is essential for haematopoiesis in zebrafish. EMBO Rep. 2006, 7:649-654.
63. Yoshida T., Hazan I., Zhang J., Ng S.Y., Naito T., Snippert H.J., Heller E.J., Qi X., Lawton L.N., Williams C.J., Georgopoulos K. The role of the chromatin remodeler Mi-2beta in hematopoietic stem cell self-renewal and multilineage differentiation. Genes Dev. 2008, 22:1174-1189.
64. Yusufzai T., Kadonaga J.T. HARP is an ATP-driven annealing helicase. Science 2008, 322:748-750.